Gene Expression Profiling Distinguishes a Molecular Signature for Grade 1B Mild Acute Cellular Rejection in Cardiac Allograft Recipients

Journal of Heart and Lung Transplantation

Volumn 26, Issue 12, 2007, Pages 1270-1280

  Bernstein, Daniel ^a   Williams, Gavin E ^b   Eisen, Howard ^c   Mital, Seema ^d   Wohlgemuth, Jay G ^b   Klingler, Tod M ^b   Fang, Kenneth C ^b   Deng, Mario C ^d   Kobashigawa, Jon ^e  

^a STANFORD UNIVERSITY   (United States)

^b XDx Inc   (United States)

^c HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; DISEASE SEVERITY; FEMALE; GENE; GENE EXPRESSION PROFILING; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIR GENE; MOLECULAR GENETICS; MOLECULAR SIGNATURE; PDCD1 GENE; POST HOC ANALYSIS; PRIORITY JOURNAL; SCORING SYSTEM; SEMA7A GENE; WDR40A GENE;

ADOLESCENT; ADULT; AGED; ALGORITHMS; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; BIOPSY; FEMALE; GENE EXPRESSION PROFILING; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEMAPHORINS; SEVERITY OF ILLNESS INDEX; UBIQUITIN-PROTEIN LIGASES;

EID: 37149043578     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.09.017     Document Type: Article

References (31)

1. Billingham M.E., Cary N.R., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 9 (1990) 587-593
2. Pardo-Mindan F.J., and Lozano M.D. "Quilty effect" in heart transplantation: is it related to acute rejection?. J Heart Lung Transplant 10 (1991) 937-941
3. Joshi A., Masek M.A., Brown Jr. B.W., Weiss L.M., and Billingham M.E. "Quilty" revisited: a 10-year perspective. Hum Pathol 26 (1995) 547-557
4. Freimark D., Czer L.S., Aleksic I., et al. Pathogenesis of Quilty lesion in cardiac allografts: relationship to reduced endocardial cyclosporine A. J Heart Lung Transplant 14 (1995) 1197-1203
5. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
6. Marboe C.C., Billingham M., Eisen H., et al. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant 24 suppl (2005) S219-S226
7. Delgado D.H., Luu L., Edwards J., et al. Should moderate acute rejection of a cardiac transplant graft be treated?. Clin Transplant 16 (2002) 217-221
8. Durham J.R., Nakhleh R.E., Levine A., and Levine T.B. Persistence of interstitial inflammation after episodes of cardiac rejection associated with systemic infection. J Heart Lung Transplant 14 (1995) 774-780
9. Fishbein M.C., Bell G., Lones M.A., et al. Grade 2 cellular heart rejection: does it exist?. J Heart Lung Transplant 13 (1994) 1051-1057
10. Frigerio M., Bonacina E., Gronda E., et al. A semiquantitative approach to the evaluation of acute cardiac allograft rejection at endomyocardial biopsy. J Heart Lung Transplant 16 (1997) 1087-1098
11. Rizeq M.N., Masek M.A., and Billingham M.E. Acute rejection: significance of elapsed time after transplantation. J Heart Lung Transplant 13 (1994) 862-868
12. Yeoh T.K., Frist W.H., Eastburn T.E., and Atkinson J. Clinical significance of mild rejection of the cardiac allograft. Circulation 86 (1992) 267-271 II
13. Nielsen H., Sorensen F.B., Nielsen B., et al. Reproducibility of the acute rejection diagnosis in human cardiac allografts. The Stanford Classification and the International Grading System. J Heart Lung Transplant 12 (1993) 239-243
14. Winters G.L., and McManus B.M. Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists. J Heart Lung Transplant 15 (1996) 728-735
15. Winters G.L., Loh E., and Schoen F.J. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted?. Circulation 91 (1995) 1975-1980
16. Milano A., Caforio A.L., Livi U., et al. Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft. J Heart Lung Transplant 15 (1996) 456-460
17. Lloveras J.J., Escourrou G., Delisle M.B., et al. Evolution of untreated mild rejection in heart transplant recipients. J Heart Lung Transplant 11 (1992) 751-756
18. Winters G.L., Marboe C.C., and Billingham M.E. The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary. J Heart Lung Transplant 17 (1998) 754-760
19. Rodriguez E.R. The pathology of heart transplant biopsy specimens: revisiting the 1990 ISHLT working formulation. J Heart Lung Transplant 22 (2003) 3-15
20. Laguens R.P., Meckert P.M., Martino J.S., Perrone S., and Favaloro R. Identification of programmed cell death (apoptosis) in situ by means of specific labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes. J Heart Lung Transplant 15 (1996) 911-918
21. Kitagawa-Sakakida S., Fukushima N., Sawa Y., et al. Microarray-based gene expression profiling of retransplanted rat cardiac allografts that develop cardiac allograft vasculopathy. J Heart Lung Transplant 24 (2005) 2068-2074
22. Schoels M., Dengler T.J., Richter R., Meuer S.C., and Giese T. Detection of cardiac allograft rejection by real-time PCR analysis of circulating mononuclear cells. Clin Transplant 18 (2004) 513-517
23. Horwitz P.A., Tsai E.J., Putt M.E., et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 110 (2004) 3815-3821
24. Deng M.C., Eisen H.J., Mehra M.R., et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6 (2006) 150-160
25. Ozkaynak E., Wang L., Goodearl A., et al. Programmed death-1 targeting can promote allograft survival. J Immunol 169 (2002) 6546-6553
26. Raimondi G., Shufesky W.J., Tokita D., Morelli A.E., and Thomson A.W. Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells. J Immunol 176 (2006) 2808-2816
27. Czopik A.K., Bynoe M.S., Palm N., Raine C.S., and Medzhitov R. Semaphorin 7A is a negative regulator of T cell responses. Immunity 24 (2006) 591-600
28. Goto E., Ishido S., Sato Y., et al. c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity. J Biol Chem 278 (2003) 14657-14668
29. Ohmura-Hoshino M., Matsuki Y., Aoki M., et al. Inhibition of MHC class II expression and immune responses by c-MIR. J Immunol 177 (2006) 341-354
30. Barrios-Rodiles M., Brown K.R., Ozdamar B., et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307 (2005) 1621-1625
31. Castello A., Dal Bello B., Klersy C., et al. Bone marrow changes in heart transplant recipients with peripheral cytopenia. Transplantation 67 (1999) 840-846